The sequences of nitric oxide synthase flavin domains closely resemble that of NADPH-cytochrome P450 reductase (CPR), with the exception of a few regions. One such region is the C-terminus; all NOS isoforms are 20-40 amino acids longer than CPR, forming a tail that is absent in CPR. To investigate its function, we removed the 21 amino acid C-terminal tail from iNOS holoenzyme and from a flavin domain construct. Both the truncated holoenzyme and reductase domain exhibited cytochrome c reductase activities that were 7-10-fold higher than the nontruncated forms. The truncated holoenzyme catalyzed NO formation approximately 20% faster than the intact form. Using stopped-flow spectrophotometry, we demonstrated that electron transfer into and between the two flavins and from the flavin to the heme domain is 2-5-fold faster in the absence of the C-terminal tail. The heme-nitrosyl-complex, formed in all NOS isoforms during NO catalysis, is 5-fold less stable in truncated iNOS. Although both CPR and intact NOS can exist in a stable, one-electron-reduced semiquinone form, neither the truncated holoenzyme nor the truncated flavin domain demonstrate such a form. We propose that this C-terminal tail curls back to interact with the flavin domain in such a way as to modulate the interaction between the two flavin moieties.
68 o C for 10 m. The PCR product was gel-purified using the GeneClean II kit (Bio101, Vista, CA) and digested with NdeI and HindIII. PCW ori+ DNA was digested with NdeI and HindIII and the ends were dephosphorylated. The two pieces were ligated and the resultant products were used to transform E. coli XL10-gold competent cells (Stratagene) using the manufacturers instructions. Positive colonies were identified by restriction digest analysis of plasmid DNA isolated from small (2 ml) cultures of select colonies.
CAMpACMIP was co-transformed with iNOSpCW-tr1 or iNOSred-tr1 into E. coli BL21 cells via electroporation using an Invitrogen Electroporator II (San Diego, CA) according to the manufacturers instructions and plated on LB agar containing 50 µg/ml ampicillin and 35 µg/ml chloramphenicol.
Protein expression/purification. Protein expression and purification are as described in Roman et al. (25) for iNOS and iNOS-tr1 and in McMillan and Masters (26) for iNOSred and iNOSred-tr1. The iNOS-tr1 and iNOSred-tr1 proteins were purified in tandem with holo iNOS and iNOSred, respectively, to reduce differences resulting from preparation to preparation.
Spectrophotometric methods. Absolute spectra and CO difference spectra were performed as described (25, 26) . The molar protein concentrations for iNOS and iNOStr1 were determined based on heme content via reduced CO difference spectra, where ε= 100 mM -1 cm -1 for ∆A 445-470 ; those for iNOSred and iNOSred-tr1 were based on total flavin concentration and ε= 21 mM -1 cm -1 at 455 nm. All spectral analyses were performed using a Shimadzu Model 2101 UV/visible dual-beam spectrophotometer.
Stopped-flow spectroscopy. Stopped-flow reactions were performed aerobically under turnover conditions at 23° C, as described in Miller et al. (19) , using an Applied Photophysics SX.18MV diode array stopped-flow spectrophotometer, which had a dead time of 2 msec. Reactions contained 3 µM enzyme, 100 µM NADPH, 10 µM H 4 B, and 100 µM L-arginine in 50 mM HEPES, pH 7.4. When the reductase domain constructs were used, L-arginine and H 4 B were omitted. Heme reduction was monitored at 397 nm and heme-nitrosyl complex formation was monitored at 436 nm. Flavin reduction was monitored at 485 nm, rather than the absorption peak value at 455 nm, to avoid spectral contamination from the heme.
Measurement of Activity. Nitric oxide formation (hemoglobin capture assay) and cytochrome c reduction were measured at 23 o C as described by Sheta, et al. (20) , with the exception that the cytochrome c reduction assays were performed in a buffer containing 50 mM HEPES, pH 7.4, in the absence of NaCl.
Oxidation of NADPH was monitored at 340 nm in the presence of 50 mM HEPES, pH 7.4, 100 µM NADPH, and 500 nM enzyme (iNOSred or iNOSred-tr1) at 23°. The rate was determined using an extinction coefficient of 6.2 mM -1 at 340 nm for NADPH.
The reoxidation of reduced flavins was monitored at 485 nm for both holoenzymes and reductase domains in the presence of 50mM HEPES, pH 7.4, 20 µM NADPH, and 2 µM enzyme at 23°.
RESULTS AND DISCUSSION
The ability of the truncated enzymes to catalyze the reduction of cytochrome c was examined and the results are shown in Table 1 . Both the wild type iNOS and its reductase domain catalyze the reduction of cytochrome c at the same rate, approximately 3000 min -1 ; for comparison, CPR also reduces cytochrome c at the same rate, i.e., 3000 min -1 (not shown). The C-terminally truncated enzymes, however, reduce cytochrome c at a rate 7-10-fold higher than the intact proteins.
Thus, the removal of 21 residues from the C-terminus of the reductase domain greatly potentiates the ability of iNOS holoenzyme and iNOSred to reduce cytochrome c.
The rate of cytochrome c reduction by iNOS-tr1 was not attenuated in the presence of superoxide dismutase and catalase ( Table 1 ), indicating that electrons were being transferred directly to the cytochrome c and not to oxygen to form superoxide, which can also reduce cytochrome c. This observation supports the contention that the increased rate of cytochrome c reduction of iNOS-tr1 is due to an increased rate of electron transfer from NADPH through the NOS flavins directly to the heme of cytochrome c and not a result of mediation by superoxide.
In the absence of a protein electron acceptor, CPR and the NOS flavin domains will shuttle electrons directly to molecular oxygen to form superoxide, albeit at a slower rate. As an indirect measurement of this process, NADPH oxidation by iNOSred and iNOSred-tr1 was monitored. iNOSred consumed NADPH at a rate of 2.1 min -1 , while iNOSred-tr1 consumed NADPH at 9.0 min -1 , an increase of 5-fold. Thus, the removal of 21 residues from the C-terminus also potentiates the ability of iNOSred to form superoxide. The rate of electron transfer to molecular oxygen is so slow in either case, however, that the formation of superoxide cannot be contributing significantly to cytochrome c reduction, in agreement with the inability of superoxide dismutase to change the reaction rate.
In view of the increased rate of electron transfer to the heme of cytochrome c, we examined whether iNOS-tr1 also had the ability to transfer electrons more rapidly from its flavins to its heme. Initially, the rate of NO production was measured. As shown in Table 1 , a difference exists in the rate of NO production between holo iNOS and iNOStr1. Although the rate of NO production by iNOS-tr1 was slightly, but consistently, higher, the difference is not as dramatic as that of cytochrome c reduction. This indicates that, whereas the rate-limiting step for cytochrome c reduction by holo iNOS is determined by its flavin domain, that of NO production is not. That is, the heme of cytochrome c is able to accept electrons as fast as NOS can transfer them; this is supported by the observation that the ratio of cytochrome c reduced to NADPH oxidized is 1:1 (data not shown). The rate of electron transfer to the heme of NOS, however, is regulated differently; the flavin domain is able to transfer electrons much faster than the heme is able to accept them. This agrees with Miller et al. (19) , who have concluded that the flavoprotein to heme electron transfer is rate-determining for initial NO production in all NOS isoforms.
To examine flavin and heme reduction of holo iNOS and iNOS-tr1 more directly, we used stopped-flow spectrophotometry under turnover conditions. Spectral changes were monitored at 485 nm (flavin reduction), 397 nm (heme reduction), and 436 nm (heme-nitrosyl complex formation) following rapid mixing of NOS with NADPH. The spectral traces are shown in Figure 1 and the actual rate constants derived from these data are shown in Table 2 . The rates for iNOS and iNOS-tr1 heme and flavin reduction are biphasic, consisting of an initial fast phase followed by a secondary slow phase.
The biphasic nature of these curves and the derived rates for holo iNOS are similar to those reported by Miller et al. (19) .
The data in Table 2 clearly show that flavin reduction is far faster than heme reduction (5-10-fold). Since the flow of electrons is from NADPH to FAD to FMN and finally to the heme (27) , the rate of reduction of the flavins and intramolecular transfer between them are certainly not limiting the rate of heme reduction, similar to the mechanism displayed by CPR (28) . The initial fast phase of flavin reduction most likely represents the conversion of the fully oxidized flavoprotein to the fully reduced and semiquinone forms. This process consists of the transfer of electrons from NADPH to the FAD moiety followed by the transfer of electrons to FMN at a rate as fast as, if not faster than, that of transfer from NADPH to the first flavin (29) . Since the transfer of electrons from FAD to FMN is so fast, the rate of the fast phase most likely reflects the rate of electron transfer from NADPH to FAD. The slower, second phase seen in the stopped-flow measurement of flavin reduction is much slower than the rate of heme reduction, too slow to be involved in transfer of electrons to the heme domain, and thereby likely represents the comproportionation of electrons, including forward and back reactions between the flavins. Table 2 shows that iNOS and iNOS-tr1 differ with respect to both phases of flavin reduction, with iNOS-tr1 exhibiting rates 2x and 5x those of iNOS for the fast and slow phases, respectively, consistent with the 10-fold increase observed in cytochrome c reduction. Similar data are obtained with the corresponding reductase domain enzymes ( Table 2 ). The rates of the fast and slow phases are 1.5-fold and 5.4-fold higher, respectively, for iNOSred-tr1 over iNOSred. Figure 2 , the amplitude of the signal for iNOSred tr-1 is twice that of iNOSred, indicating that, while iNOSred initially forms the stable, oneelectron-reduced semiquinone, iNOSred-tr1 does not, instead becoming fully oxidized.
This behavior is also observed with the holo iNOS and iNOS-tr1 (not shown). The slope of the line represents the rate of flavin oxidation and it is clear that this rate for iNOSred-tr1 is twice that of iNOSred, which is consistent with both flavins being rapidly and fully oxidized, rather than just one as in the semiquinone form. To directly address this difference between holo and truncated enzymes, the same reaction was performed, but monitored at 585 nm, which specifically measures the neutral semiquinone form (28) . For iNOSred, the semiquinone form accumulates steadily until it reaches a plateau at about 180 sec, which persists for the remaining 120 sec of the experiment (data not shown). This is entirely consistent with the data shown in Figure 2 , where the change in absorbance reflecting reoxidation of one flavin occurs between 170 and 210 sec. With iNOSred-tr1, such an accumulation and persistence are not seen.
The reduction of heme in iNOS is also a biphasic reaction and, interestingly, is unique to this isoform. nNOS and eNOS heme reduction are both monophasic under the conditions of our experiments (19) . It is evident from the data in Table 2 that there are only small differences in heme reduction between iNOS and iNOS-tr1, with the fast and slow phases of iNOS-tr1 being 1.2-fold and 2.4-fold higher, respectively, than those of iNOS. It is unclear what the two phases of the reaction represent, but perhaps a clue comes from the work of Abu-Soud et al. (31) , who showed that nNOS becomes inactivated during catalysis due to the rapid formation of a heme-nitrosyl complex between the enzyme and the NO it generates. This NO can also bind to and inactivate the ferric form of the enzyme and, while in nNOS the ferrous form is primarily produced, it is the ferric-NO complex that predominates in an aerobic environment with iNOS (32) .
As much as 70-90% of the enzyme may be present in the inactive form during the steady state. The heme-nitrosyl complex is also formed with eNOS, which forms the complex the most slowly, while iNOS forms it the most rapidly of all the isoforms (19) .
Thus, heme reduction during catalysis would demonstrate an initial fast phase, because no heme-nitrosyl complex is present, followed by a slower phase, reflecting both an equilibrium between free and nitrosyl-complexed heme and the inability of this nitrosylcomplexed heme to bind oxygen until it dissociates. Comparing the data in Figure 1 for wavelengths 397 nm (heme reduction) and 436 nm (nitrosyl-complex formation) shows that there is a lag in the onset of nitrosyl complex formation of almost 20 msec, in the case of iNOS-tr1, which corresponds with the onset of the second phase of heme reduction. This behavior is less clear for the wt enzyme, where nitrosyl complex formation is faster and heme reduction is slower; in this case, the lag is about 8 msec.
This biphasic behavior in heme reduction thus represents a switch in the rate-limiting step from heme reduction to the dissociation of the heme-nitrosyl complex (33) . AbuSoud et al. (34) demonstrated that the off-rate of NO from the ferric-NO complex of an iNOS heme domain construct is 13 ± 3 sec -1 (at 10°C), which is similar to our value for the slow phase of heme reducton in the holo-enzyme at 25°C.
As shown in Table 2 , iNOS forms the heme-nitrosyl complex at a rate of 105 sec ↑ 1, while iNOS-tr1 forms this complex four-fold slower (26 sec -1 ). Perhaps the more rapid flux of electrons into the heme, reflected by the 20% increase in the fast phase, affects either the association or dissociation of the heme-nitrosyl complex formation.
Thus, these two factors, the increase in the rate of heme reduction (fast phase) and the decreased formation and/or destabilization of the heme-nitrosyl complex, which results in an apparent increase in the slow phase of heme reduction, account for the slightly higher rate of NO formation of iNOS-tr1 over iNOS.
Although the removal of the C-terminal tail residues has some effect on the function of the heme domain in this enzyme, the majority of the effect is obviously in the function of the flavin domain. iNOS-tr1 transfers electrons faster into the FAD from NADPH (fast phase of flavin reduction) and from the flavin domain to the heme domain (fast phase of heme reduction) than intact iNOS. The steady-state level of flavin semiquinone, i.e., a form containing a one-electron-reduced FMN moiety, in the truncated enzymes is very low. Based on the flow of electrons depicted in Scheme 1, the rate constant of electron transfer either to the heme (k 4 ) or to FAD (k 3 ) is necessarily faster in the truncated enzymes than in the intact enzymes. Since the rate of cytochrome c reduction is greatly potentiated in the truncated forms, the increase must be in k 4 . This is also reflected in the higher rate of heme reduction and NO and superoxide formation by iNOS-tr1. This accelerated electron transfer to the heme domain also results in a decreased rate of formation or increased rate of dissociation of the heme-nitrosyl complex.
Comproportionation of the electrons between the FMN and FAD, described by the rate constants k 2 and k 3 and reflected by the slow phase of flavin reduction in the stopped-flow experiments, also varies significantly between the intact and truncated enzymes. Since k 2 is extremely fast and k 4 is faster in the truncated enzyme than in the intact enzyme, k 3 must be decreased in iNOS-tr1.
Interestingly, although the C-terminus is also involved in the stabilization of the one-electron-reduced semiquinone form of iNOS, CPR, which does not have the Cterminal tail and which iNOSred-tr1 was created to mimic, does form the air stable oneelectron-reduced semiquinone. Thus, whatever role the C-terminal tail plays in the stabilization of the semiquinone form of iNOS is served differently in CPR. Although the reductase domains of the NOSs are thought to be very similar in structure to CPR, there must be differences in the way the two flavins interact with each other. The FAD-binding portion of the nNOS flavin domain has been crystallized and was shown to be n/a a n/a Slow phase 11.1 ± 0.06 26.6 ± 0.44 n/a n/a Heme-nitrosyl complex formation (436 nm) 105 ± 2.27 25.6 ± 0.15 n/a n/a * All numbers are reported in the unit of sec - a not applicable
